Denise Laspina represents both plaintiffs and defendants in actions pending before federal district courts in high-stakes litigation. Her practice focuses primarily on patent litigation involving pharmaceutical innovators.

Denise served as a clerk for Judge Evelyn Padin of the United States District Court for the District of New Jersey.

Before joining Latham, Denise earned her JD from the University of Michigan School of Law, where she served as a senior editor on the Michigan Law Review. Prior to attending law school, Denise worked at academic research institutions, investigating drug candidates for neurodegenerative diseases and cancer. Denise earned her bachelor’s degree in biology with a focus on neuroscience from Stony Brook University.

Denise’s recent experience includes representing:

  • AbbVie in:
    • Hatch-Waxman litigation involving Rinvoq®
    • Hatch-Waxman litigation involving Bruton-tyrosine kinase inhibitors
  • Johnson & Johnson in BPCIA litigation involving Stelara®
  • Avadel Pharmaceuticals in Hatch-Waxman litigation involving Lumryz®

Bar Qualification

  • District of Columbia
  • New York

Education

  • JD, University of Michigan Law School, 2022
    cum laude, Senior Editor, Michigan Law Review, Darrow Scholar
  • BS in Biology, Stony Brook University, 2016

Languages Spoken

  • English
  • Spanish